SYNTHON BV
GenericsSYNTHON BV is a generic drug manufacturer focused on Neurology.
SYNTHON BV's Key Drugs
SYNTHON BV's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SYNTHON BV's Recent FDA Approvals
New NDA/BLA approvals for SYNTHON BV over the last two years — novel drugs only, excluding generics and label supplements.
SYNTHON BV's Therapeutic Areas
SYNTHON BV's approved drugs and pipeline span 1 therapeutic area, led by Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SYNTHON BV's Top Competitors
SYNTHON BV's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SYNTHON BV Pipeline Snapshot
SYNTHON BV has 1 active clinical program from ClinicalTrials.gov — 1 Phase 3, 0 Phase 2 and 0 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2010-04-27
- Latest
- 2025-07-11
- Applications
- 5